Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Generic semaglutide in India, and other weight-loss news - pharmaphorum pharmaphorum Novo Nordisk is facing generics of its GLP-1 drug in India, Atrogi is testing a new weight loss approach, and there's new data on Structure's lead ... Flag as irrelevant
	Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India | Reuters Reuters India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires this week ... Flag as irrelevant
	Study: Many patients stop popular weight-loss drugs within a year - YouTube YouTube Researchers say many patients quit obesity medications within a year. Experts warn stopping treatment may impact long-term weight loss success. Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds Euronews.com GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, ... Flag as irrelevant
	Pythons' feast-and-famine life hints at new weight-loss pathway - Stanford Medicine Stanford Medicine - Stanford University ... identified molecules that skyrocket in their blood after a meal. One caused obese mice to eat less and lose weight, similar to semaglutide. Flag as irrelevant
	Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial Scientific American Retatrutide is among a new class of weight loss drugs being tested for their effectiveness. Flag as irrelevant
	FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight ... PR Newswire Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment* with Wegovy® HD (~19% regardless of whether ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Weight loss jabs are no quick fix, health boss warns - BBC BBC Weight loss jabs should not be viewed simply as a "quick fix" and people need to consider their wider relationship with food, ... Flag as irrelevant
	Lainey Wilson highlights 20lbs weight loss in sheer shirt and leather pants for stunning new ... HELLO! Magazine Country music star Lainey Wilson showed off her 20lbs weight loss in a sheer shirt, studded bra, and tight leather pants at the Lainey Wilson: ... Flag as irrelevant
	Lilly's Retatrutide Shows Significant Improvement In Weight Loss and Blood Sugar - WSJ WSJ The Eli Lilly logo in red on the side of a building. Eli Lilly's experimental weight-loss drug retatrutide met the primary and key secondary endpoints ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Eli Lilly's 'Triple Agonist' Is More Than Just a Weight-Loss Drug. This Trial Proves It. Barron's ... lose weight and reduce blood sugar levels. (Dreamstime). Key Points. About This Summary. Eli Lilly's new drug candidate, retatrutide, a triple ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Weight-loss treatment is on the verge of a dramatic shift – again | CNN CNN About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400000 Americans. Flag as irrelevant
	The Power Foods Diet: Eat A Lot and Lose Weight | Dr. Jim Loomis and Caryn Dugan Physicians Committee for Responsible Medicine Why eating MORE fiber-rich foods can actually help you lose weight; The powerful connection between food, metabolism, and chronic disease; How to ... Flag as irrelevant
	Weight loss jabs may help with anxiety and depression, study finds - Sky News Sky News Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening ... Flag as irrelevant
	Wegovy Pill vs. Injection: Which Is More Effective? - Women's Health Women's Health Which Is Better: The Weight Loss Pill or Injection? How to decide which GLP- ... Flag as irrelevant
	Lilly's Experimental Diabetes Shot Yields Record Weight Loss in Study - Bloomberg News Bloomberg News One of Eli Lilly & Co.'s most highly anticipated experimental medicines helped diabetic patients lose more weight than any drug currently on the ... Flag as irrelevant
	The missing piece in medical weight loss: Why behavioral support is crucial for long-term success Montgomery County Sentinel (BPT) - GLP-1 medications have been reshaping treatment of obesity and weight management, but health experts agree that these groundbreaking ... Flag as irrelevant
	What are obesogens? Sneaky metabolism killer lurks around your home - New York Post New York Post Here's everything you need to know about obesogens — including steps you can take to reduce exposure — so your weight loss efforts can finally pay ... Flag as irrelevant
	Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test - Fierce Biotech Fierce Biotech Eli Lilly is rounding out its pitch for retatrutide with new data looking at blood sugar reductions and weight loss in patients with Type 2 ... Flag as irrelevant
	Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial Investor's Business Daily Eli Lilly reported its experimental drug retatrutide delivered stronger weight loss than current treatments. Eli Lilly stock edged lower. Flag as irrelevant
	U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop U.S. News & World Report This decline was most obvious among 10th- and 12th-graders. "In the U.S. today, adolescent obesity rates continue to rise while weight-loss attempts ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback